feed,title,long_url,short_url
SSRN,Tolerability and Immunogenicity After a Late Second Dose or a Third Dose of ChAdOx1 nCoV-19 (AZD1222),https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3873839,
SSRN,Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3874014,
